» Articles » PMID: 12437272

A Simulation to Evaluate Screening for Helicobacter Pylori Infection in the Prevention of Peptic Ulcers and Gastric Cancers

Overview
Specialty Health Services
Date 2002 Nov 20
PMID 12437272
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

A discrete event simulation model has evaluated a screening programme for Helicobacter pylori infection (H. pylori) in which individuals under the age of 50 years would be screened once. Eradication of H. pylori would reduce the peptic ulcer risk immediately and the gastric cancer risk after a fixed delay. The data were derived from published databases and peer reviewed papers. The simulation model, using variance reduction techniques, predicted that a screening programme would reduce morbidity and deaths but could cost around 19 million pounds for England and Wales in the first year of screening. A factorial design analysis showed the sensitivity of key variables. An increase in the opportunistic testing was found significantly to reduce the impact of screening.

Citing Articles

Evolving Concepts in Helicobacter pylori Management.

Moss S, Shah S, Tan M, El-Serag H Gastroenterology. 2023; 166(2):267-283.

PMID: 37806461 PMC: 10843279. DOI: 10.1053/j.gastro.2023.09.047.


Simulation Models in Gastric Cancer Screening: A Systematic Review.

Matsuda A, Saika K, Tanaka R, Ito Y, Fukui K, Kamo K Asian Pac J Cancer Prev. 2018; 19(12):3321-3334.

PMID: 30583337 PMC: 6428531. DOI: 10.31557/APJCP.2018.19.12.3321.


Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.

Kowada A Epidemiol Infect. 2018; 146(14):1834-1840.

PMID: 30056808 PMC: 9506699. DOI: 10.1017/S095026881800208X.


Cost-effectiveness analysis of universal noninvasive testing for post-treatment confirmation of Helicobacter pylori eradication and the impact of patient adherence.

Boklage S, Mangel A, Ramamohan V, Mladsi D, Wang T Patient Prefer Adherence. 2016; 10:1025-35.

PMID: 27354772 PMC: 4908940. DOI: 10.2147/PPA.S102760.


Impact of patient adherence on the cost-effectiveness of noninvasive tests for the initial diagnosis of Helicobacter pylori infection in the United States.

Boklage S, Mangel A, Ramamohan V, Mladsi D, Wang T Patient Prefer Adherence. 2016; 10:45-55.

PMID: 26855566 PMC: 4727507. DOI: 10.2147/PPA.S93320.


References
1.
. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut. 1993; 34(12):1672-6. PMC: 1374460. DOI: 10.1136/gut.34.12.1672. View

2.
Kurata J, Nogawa A . Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol. 1997; 24(1):2-17. DOI: 10.1097/00004836-199701000-00002. View

3.
Patel P, Khulusi S, Mendall M, Lloyd R, Jazrawi R, Maxwell J . Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet. 1995; 346(8986):1315-8. DOI: 10.1016/s0140-6736(95)92340-3. View

4.
Lind T, van Zanten S, Unge P, Spiller R, Bayerdorffer E, OMorain C . Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996; 1(3):138-44. DOI: 10.1111/j.1523-5378.1996.tb00027.x. View

5.
Forman D, Webb P, Parsonnet J . H pylori and gastric cancer. Lancet. 1994; 343(8891):243-4. View